C1QTNF3 and diabetes mellitus: It is worth noting that, in our pilot experiments, CTRP3 failed to exert a significant protective effect in the diabetes-induced severe DR mice model (PDR model) (18 weeks after diabetes onset), suggesting that early treatment with CTRP3 is crucial.